000 01317 a2200409 4500
005 20250513212628.0
264 0 _c20000713
008 200007s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.54.11.2176
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTim, R W
245 0 0 _aLambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment.
_h[electronic resource]
260 _bNeurology
_cJun 2000
300 _a2176-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a4-Aminopyridine
_xanalogs & derivatives
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAmifampridine
650 0 4 _aCarcinoma, Small Cell
_xdiagnosis
650 0 4 _aCarcinoma, Squamous Cell
_xdiagnosis
650 0 4 _aElectrodiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLambert-Eaton Myasthenic Syndrome
_xdiagnosis
650 0 4 _aLung Neoplasms
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPotassium Channels
_xtherapeutic use
700 1 _aMassey, J M
700 1 _aSanders, D B
773 0 _tNeurology
_gvol. 54
_gno. 11
_gp. 2176-8
856 4 0 _uhttps://doi.org/10.1212/wnl.54.11.2176
_zAvailable from publisher's website
999 _c10802491
_d10802491